GNI Group Ltd 3G6-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:11 AM CEST
8.60quote price arrow down-0.40 (-4.44%)
52 week range
7.15 - 14.20
Loading...
  • Open8.60
  • Day High8.60
  • Day Low8.60
  • Prev Close11.60
  • 52 Week High14.20
  • 52 Week High Date08/16/22
  • 52 Week Low7.15
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap428.96M
  • Shares Out47.46M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.52

KEY STATS

  • Open8.60
  • Day High8.60
  • Day Low8.60
  • Prev Close11.60
  • 52 Week High14.20
  • 52 Week High Date08/16/22
  • 52 Week Low7.15
  • 52 Week Low Date05/12/22
  • Market Cap428.96M
  • Shares Out47.46M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-22.52

RATIOS/PROFITABILITY

  • EPS (TTM)0.12
  • P/E (TTM)71.67
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GNI Group Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GNI Group Ltd. is a Japan-based company engaged in new drug production activities utilizing biotechnologies. The Company is engaged in the development of therapeutic agents for diseases that have many sufferers in Asian countries such as Japan and China, as well as clinical trial and bio-verification test businesses. It is engaged in research and development of therapeutic agents, including F647 for radiation pneumonia (RP) and idiopathic pulmonary fibrosis (IPF), F351 for...
Ying Luo Ph.D.
Executive President, Chief Executive Officer, Representative Executive Officer, Chairman of Subsidiaries, Director
Joseph Meyer
Chief Financial Officer, Executive Officer, Director
Address
3F, Nihonbashi-Honcho YS Bldg
2-2-2, Nihonbashi Hon-cho
Chuo-ku, TKY
103-0023
Japan